Get started
Author

Jean Lang

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
2012 · Arunee Sabchareon, Derek Wallace, et al. · The Lancet · 817
From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
2011 · Bruno Guy, Beatrice Barrere, et al. · Vaccine · 323
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
2009 · Bruno Guy, Farshad Guirakhoo, et al. · Vaccine · 291
Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
2004 · F. Guirakhoo, K. Pugachev, et al. · Journal of Virology · 251
Treatment of Severe Colchicine Overdose with Colchicine-Specific Fab Fragments
1995 · Frédéric J. Baud, Alain Sabouraud, et al. · New England Journal of Medicine · 228
PDF
Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All
2006 · Farshad Guirakhoo, Scott Kitchener, et al. · Human Vaccines · 197
PDF
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
2002 · Arunee Sabchareon, Jean Lang, et al. · American Journal of Tropical Medicine and Hygiene · 183
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
2015 · Bruno Guy, Olivier Briand, et al. · Vaccine · 173
PDF
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
2010 · Dennis Morrison, Thomas J. Legg, et al. · The Journal of Infectious Diseases · 165
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
2004 · ARUNEE SABCHAREON, JEAN LANG, et al. · The Pediatric Infectious Disease Journal · 145
Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model
2009 · Bruno Guy, Veronique Barban, et al. · American Journal of Tropical Medicine and Hygiene · 139
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
2008 · Bruno Guy, Nolwenn Nougarede, et al. · Vaccine · 137
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults☆
2005 · S KITCHENER, M NISSEN, et al. · Vaccine · 132
Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
2011 · Rosario Z. Capeding, Imelda A. Luna, et al. · Vaccine · 130
Development of sanofi pasteur tetravalent dengue vaccine
2010 · Bruno Guy, Melanie Saville, et al. · Human Vaccines · 126
PDF
Antibody Persistence Following Preexposure Regimens of Cell‐Culture Rabies Vaccines: 10‐Year Follow‐Up and Proposal for a New Booster Policy
1998 · Alain Strady, Jean Lang, et al. · The Journal of Infectious Diseases · 113
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
2010 · Jorge Poo, Francisco Galan, et al. · The Pediatric Infectious Disease Journal · 110
Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.
1999 · J Lang, J Zuckerman, et al. · American Journal of Tropical Medicine and Hygiene · 89
Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique
1998 · L. Thomas, B. Tyburn, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 72
Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine
1998 · J. Lang, P. Attanath, et al. · Acta Tropica · 68
Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
2011 · Ming Qiao, David Shaw, et al. · American Journal of Tropical Medicine and Hygiene · 67
PDF
High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale production
2006 · V. Barban, Y. Girerd, et al. · Vaccine · 67
Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
2006 · Violette Sanchez, Sophie Gimenez, et al. · Vaccine · 67
A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam
2010 · Nguyen Thi Kim Tien, Christine Luxemburger, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 64
Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine
1998 · ARUNEE SABCHAREON, PORNTHEP CHANTAVANICH, et al. · The Pediatric Infectious Disease Journal · 63
Works count: 108
Citation count: 6,449
H-index: 45
I10-index: 84
Year
Topic
Type